T cell repertoire alterations occurring after allogeneic BMT and related emergence of aGVHD has not been directly demonstrated. CD4, CD8 and V␤ usage of T cells infiltrating spleen, lymph nodes and liver was compared in lethally irradiated F1(DBA/2 ؋ B10.D2) recipients which develop (GVHD mice) or not (long survivor:LS mice) aGVHD across minor histocompatibility antigens (mHAgs) and Mtv-6 and Mtv-7 encoded superantigens (SAgs) barriers according to experimental conditions. The early expansion in GVHD mice of CD4V␤6 ؉ and of CD4V␤3 ؉ T cell subsets specific for Mtv-7 and Mtv-6 SAgs, respectively, is abolished in LS protected mice. By contrast, CD8
versus-leukemia effect (GVL). Previous data have shown that CD4
+ and CD8 + cells are involved in GVHD depending on the nature of the incompatibilities between donor and recipient. 5, 6 Detailed analysis of the T cell repertoire has already described frequent alterations consisting of selective expansion of some V␤ subpopulations in the spleen and the liver of mice developing GVHD across minor histocompatibility barriers 7 and also in skin and/or blood of patients following allogeneic BMT. [8] [9] [10] [11] [12] [13] [14] In our experimental model, lethal GVHD develops in irradiated F1(DBA/2 × B10.D2) mice transplanted with MHC identical B10.D2 lymphoid cells 1 incompatible for multiple DBA/2 mHAgs and for Mls-1 a and Mls-2 a superantigens (SAgs) encoded by the endogenous mouse mammary tumor viruses Mtv-7 and Mtv-6, respectively. 15 T cell depletion experiments and clonal analysis have shown that predominantly CD4 +5, 16 but also CD8 +5,17 T cells are implicated in the induction of GVHD mortality in this genetic combination. In addition, we recently reported that the incidence or rate of GVHD mortality is related to the number and type of Mtv present in the recipient's genome and that soon after the graft GVHD target organs are strongly infiltrated by CD4V␤6
+ and CD4V␤3 + T cells specific for Mtv-7 and Mtv-6 SAgs, respectively. 18 We proposed that Mtv encoded SAgs could be responsible for the initiation or the severity of GVHD by activating a large population of T cells. In the same genetic combination, the lethal GVHD can be prevented by preimmunizing B10.D2 donors with DBA/2 splenocytes 3 days before the graft. 19 F1 recipients become chimeric and long survivors (referred to as LS mice). 20 Although these mice are specifically tolerant at the level of CD4 + proliferative response, they are still able to perform CD8-mediated cytotoxicity against host mHAgs.
20, 21 Models of induction and prevention of GVHD provide the opportunity to confirm the hypothesis of the role of Mtv-SAgs-specific T cells in lethal GVHD and to further characterize T cell populations involved in the disease.
In this report, the comparative study of the T cell repertoire infiltrating GVHD target organs shows that the early Mtv-SAgs-specific CD4 + T cell infiltration seen in GVHD mice is no longer observed in protected LS mice. From day 10 after the graft, the lymph nodes and the liver of both GVHD and LS mice are infiltrated by CD8 + T cells. Selective expansion of one or more V␤ subsets is found in CD4 + and CD8
+ compartments of GVHD and mostly in the CD8 + compartment of LS mice. Yet, the pattern of overexpression is unique to each mouse indicating the absence of the repertoire bias linked with the pathology. These data suggest that the activation of the CD4 + T cell repertoire directed against mHAgs and Mtv-SAgs is crucial for acute GVHD development.
Materials and methods

Mice
, Mtv-6 + , Mtv-7 + ) were purchased from Jackson Laboratories (Bar Harbour, ME, USA) and bred in our animal facilities under pathogen-free conditions.
GVHD induction and protection
F1(DBA/2 × B10.D2) recipient mice were lethally irradiated (9.5 Gy) using a cesium source (RX 30/55 M irradiator; Gravatom Industries, Gosport, UK) and grafted i.v. with 10 7 bone marrow and 8 × 10 6 spleen cells from donor B10.D2 mice (referred as to GVHD mice). Mice protected from GVHD (referred as to LS mice) were obtained by grafting F1 recipients with cells from B10.D2 donor mice previously immunized i.v. with 2 × 10 7 DBA/2 spleen cells.
Liver T cell purification
Livers from grafted mice were cut into small pieces, passed through an iron filter and washed with 1640 RPMI medium supplemented with 30% FCS. The suspension was submitted to a Ficoll-Hypaque gradient, washed and the pellet was resuspended into RPMI 1640 medium supplemented with 10% FCS and the number of cells estimated. 22 
Cytofluorometric analysis
Lymphocytes from spleen, lymph nodes and liver were collected from GVHD and LS mice at different times after the graft and stained with both PE-conjugated anti-CD4 and FITC-conjugated anti-CD8 mAbs as described previously. 18 Cells were also stained with biotinylated anti-V␤ mAb revealed by a FITC-conjugated streptavidin (Pharmingen, Clinisciences, Montrouge, France) and with PE-conjugated anti-CD4 or anti-CD8 mAbs.
CD8
+ -specific subset purification Liver cells (2 × 10 6 ) were incubated with 5 l of CD8-coated MACS magnetic microbeads (Miltenyi Biotec, Bergisch-Gladbach, Germany) for 20 min at 4°C. Beadcoated CD8
+ cells were separated on a magnet (MACS) and the degree of purity was checked by staining with conjugated anti-CD4 and anti-CD8 mAb.
RNA extraction and cDNA synthesis
Total RNA was extracted with RNABle (Eurobio, Les Ulis, France) according to the manufacturer's conditions. Single strand cDNA was synthesized using the First Strand Synthesis kit (Pharmacia Biotech, Orsay, France) and then diluted in 30 l of water.
PCR amplification and direct sequencing
PCR was performed using the 3′ primer C␤ AAAAGGCTACCCTCGTGTGCTTG and the 5′ primers V␤2 TCACTGATACGGAGCTGAGGCT, V␤4 GCC-TCAAGTCGCTTCCAACCT, V␤6 CTCTCACTGTGAC-ATCTGC, V␤8.1 CATTCTGGAGTTGGCTTCCC, V␤8.2 GTCTGTAGAGCCGGAGGA and V␤10 AGGGTCTGT-AGAGCCGGAGGAC. cDNA 1/30 was submitted to amplification by PCR with 12.5 pM of V␤-and C␤-specific oligonucleotides in the presence of 2.5 mM MgCl 2 , 10 mM dNTPs, 1.5 U Taq polymerase. The mixtures were submitted to 35 cycles, each consisting of 45 s at 94°C, 1 min at 60°C, and 1 min at 72°C. PCR products were purified using a Wizard DNA clean up system (Promega, Charbonnières, France) and directly sequenced using the Cyclist Taq DNA Sequencing Kit (Stratagene, Ozyme, Montigny, France), 33 P-labeled dATP (NEN, Dupont de Nemours, Les Ulis, France) and the same V␤-specific primers.
Statistical analysis
A
2 test was performed to compare the percentages of mice exhibiting a given overexpressed V␤ subpopulation in GVHD and LS mice.
Results
Phenotype of cells infiltrating organs of GVHD or protected mice
We previously demonstrated that 7 days after the graft, TCR ␣␤ + T cells which are of a B10.D2 donor origin, represent 45-80% of cells infiltrating the spleen, lymph nodes, liver and bowel of GVHD mice.
18 Figure 1 confirms these data and shows that CD4 + T cells predominate early after the graft in all GVHD target organs. Additionally, the percentage of CD8 + T cells, very low on day 7 after the graft, progressively increases in the lymph nodes and liver but not in the spleen, where a rapid GVHD-mediated T cell depletion occurs. The values of CD4 and CD8 on day 0 represent the percentage of these subpopulations in the corresponding organ of untreated B10.D2 donor mice.
In LS mice, CD4 + T cell infiltration was not observed in the spleen or the liver whereas it appeared in the lymph nodes on day 7 but decreased rapidly. As in GVHD mice, a recruitment of CD8 + cells occurs only in the lymph nodes and liver, with a maximum noted on day 14 ( Figure 1 ).
V␤ T cell repertoire in GVHD and LS mice
We further analyzed the V␤ repertoire within CD4
+ and CD8 + compartments in the spleen, lymph nodes and liver of GVHD and LS mice. Individual mice were sacrificed between days 7 and 27 after the graft and cells from the different organs were stained with seven anti-V␤ mAbs. Anti-V␤5 and -V␤11 were not used because donors and recipients express I-E class II molecules and Mtv-SAgs which leads to the deletion of these V␤ subsets. A V␤ subpopulation was considered to be significantly increased when its percentage exceeded the average percentage of normal B10.D2 mice plus 3 s.e. in the corresponding organ.
Analysis of CD4 + T cell repertoire
Cytofluorometric analysis of GVHD mice on day 7 previously revealed that CD4 + infiltration in all three GVHD target organs is essentially due to the expansion of V␤6 + and V␤3
+ T cell subpopulations specific for Mtv-7-and Mtv-6-SAgs, respectively. 18 These results are confirmed in Table 1 which indicates that percentages of these subsets account for 45-65% of total CD4 + T cells. The same study performed in LS mice demonstrated the absence of CD4V␤6 + T cell expansion in both the liver and the spleen (Table 1) . In lymph nodes, where CD4
+ infiltration still occurred early after the graft (Figure 1 ), 21% of CD4 + cells express the V␤6 segment. This corresponds to the percentage of V␤6 + T cells within the CD4 + T cell subset from the DBA/2 preimmunized B10.D2 donor ( T cells in the lymph nodes of LS mice. Concerning the CD4V␤3 + subset, an absence of infiltration was observed in the lymph nodes and liver but was still apparent in the spleen (16%) although at a lesser degree than in GVHD mice. On day 7, the percentages of other V␤CD4 + T cell subsets in GVHD and LS mice remained unchanged (Table 1 and data not shown) or had decreased. Fourteen to 27 days after the graft, individual CD4
+ T cell repertoire analysis has shown that significant overexpressions of some other V␤ subpopulations such as V␤2 + , V␤4 + , V␤6 + and V␤10
+ cells appeared frequently in the liver of GVHD mice but never (V␤4 and V␤10) or only occasionally (V␤6) in the liver of LS mice (Table 2) . A similar analysis was performed in the lymph nodes where very scarce V␤ overexpressions were detected both in GVHD and LS mice (data not shown).
Analysis of CD8
+ T cell repertoire
The same approach was performed within the CD8 + compartment from day 14 because before this time the number (Tables 3 and 4 ). However these overexpressions were more frequent in the liver than in the lymph nodes. Comparison between GVHD and LS mice revealed that: (1) 40-60% of mice had an increased percentage of V␤4 + T cells both in lymph nodes (Table 3 ) and the liver (Table 4) ; (2) CD8V␤10 + T cell overexpression was observed in the liver of 5/17 GVHD mice and not in the liver of LS mice (Table 4 , P Ͻ 0.02); and (3) CD8V␤8.2 + T cells were specifically expanded in the lymph nodes of LS and not of GVHD mice (Table 3 , P Ͻ 0.05).
Clonality of over-represented V␤ subsets
V␤ overexpression among T cells in both GVHD and LS mice could be due to clonal or polyclonal T cell expansion reflecting either an antigen-driven T cell recruitment or a random reconstitution, respectively. To answer this question, cDNA was synthesized using RNA extracted from CD8 + liver cells (purified up to 91.9%) from five GVHD and five LS mice sacrificed 14 to 22 days after the graft. To analyze the TCR ␤ chain repertoire within overexpressed V␤CD8 + T cell subsets and also within non-overexpressed V␤CD8 + T cell subsets as controls (previously defined by immunofluorescence analysis), we characterized the CDR3 region by submitting cDNA to amplification by PCR using C␤2 and the corresponding V␤-specific primers. The purified PCR products were directly sequenced and J␤ segments and junctional regions were determined when possible. Three types of data have been obtained: (1) the sequence is unreadable and thus we conclude that the T cell population is polyclonal; (2) the J␤ segment can be assigned but the N junction cannot be defined (oligoclonal); this situation reflects the expansion of several T cells using preferably one given J␤ segment; and (3) J␤ and N junctions can be determined indicating the expansion of one major T cell clone. The results depicted in Table 5 indicate a correlation between the significant amplification of a given V␤ population and the characterization of the J␤ segment and/or the junctional region. Indeed, 4/5 (80%) and 6/8 (81%) overexpressed V␤CD8 + T cell subsets found in the liver of GVHD and LS mice, respectively, corresponded to clonal or oligoclonal populations. In addition, within the 26 non-overexpressed V␤CD8 + T cell subsets sequenced, 20 corresponded to polyclonal populations and six corresponded to clonal or oligoclonal populations. It is interesting to note that five of the latter non-overexpressed clonal or oligoclonal T cell subpopulations expressed the TCR V␤2 segment associated with various J␤ segments. These results indicate that the majority of overexpressed V␤CD8 + T cells were due to the expansion of one predominant or a very limited number of T cell clones. Yet the identity of J␤ segments associated with the V␤ segment differs between mice and no repeated sequences have been found among the different overexpressed T cells, strongly suggesting that these T cell populations proliferated in response to many different antigens.
Discussion
Several studies have focused on the T cell repertoire emerging during GVHD in humans and in mice to determine if a limited number of clones could be involved in the disease and thus if a specific depletion of donor inoculum could be envisaged to prevent the development of GVHD. However, analyses performed in humans are complicated by the variability of donor-recipient combinations in terms of incompatible antigens and the T cell repertoire involved as well as the occurrence of opportunistic infections. To circumvent these problems and to answer the question of a possible T cell repertoire specifically involved in GVHD, we have studied a murine model in which bone marrow grafting takes place between MHC-identical, mHAgs, Mtv-6 and -7 incompatible individuals but where GVHD develops or not according to donor treatment. 19 Our findings clearly show that the early strong infiltration observed in the target organs of GVHD mice of CD4V␤6 + and CD4V␤3
+ T cells specific for Mtv-SAgs 18 is completely inhibited in LS mice in the absence of disease. The mechanism involved in the inhibition of Mtv-SAgs-specific T cell response in vivo has not yet been defined. Yet preimmunization of B10.D2 donors with DBA/2 splenocytes leads to the emergence of TCR ␣␤ CD3 + CD4 − CD8 − double negative T cells which inhibit the T cell response against Mtv-SAg in vitro and prevent the development of GVHD in vivo. 23 On the other hand, the preimmunization renders anergic Mtv-SAgs-specific T cells. 23, 24 Our observations question the role of Mtv-SAgs-specific T cells in GVHD: do they behave as effectors of the reaction or do they mediate an inducer/helper effect? The former hypothesis is unlikely because the injection of T cells collected from LS mice that are reactive to Mtv-SAgs 2-3 months after the graft 18 and of CD4 + T cell clones specific for Mls- 16 does not induce GVHD mortality when transferred into irradiated F1 recipients. It is more likely that Mtv-SAgs mediate an inducer/helper effect by activating V␤-specific polyclonal T cell populations which release large amounts of cytokines upregulating MHC molecules among others. Additional experiments indicate that the high levels of cytokines (IL-2, IL-4 and IFN␥) released by T cells from GVHD mice just after the graft is reduced in LS mice (data not shown). In line with our data, Jones et al 25 reported that GVHD occurring in an H-2 compatible donor-recipient combination, which includes an Mtv-6 SAg disparity, spleen and lymph nodes are infiltrated by CD4V␤3 + T cells which secreted IFN␥. These observations strongly support a crucial role for Mtv-SAg-specific CD4 + T cells, the degree of activation of which influences the initiation or exacerbation of GVHD. Could these observations be extended to other GVHD murine models and also to human transplantation? Incompatibility for Mtv is not particularly associated with this genetic combination since all strains of mice display a specific pattern of two to eight endogenous proviruses in their genome. In addition, although Mtv-7-SAg is the only SAg that induces a primary proliferative response of V␤6 + T cells in vitro, it was reported by us and other workers 18, 25, 26 (and data not shown), that V␤3 + T cells specific for Mtv-1, -6, -13 SAgs and V␤11 + T cells specific for Mtv-8, -9 and -11 SAgs expand in vivo after injection to irradiated recipients expressing these respective Mtv in their genome. Extrapolation to human transplantation is less straightforward as endogenous SAgs have not yet been evidenced in humans. However, bacteria 27 and more recently Epstein-Barr virus 28 and cytomegalovirus 29 were shown to be associated with superantigenic responses stimulating V␤13 + and V␤12 + T cells, respectively. Interestingly, the presence of these infectious agents is known to increase the risk of GHVD in grafted patients. 30 The preferential expansion of SAgs-specific CD4 + cells must not obscure the potential role of CD4 + cells reacting with host mHAgs as effectors of GVHD. We have previously demonstrated the capacity of CD4 + T cell clones specific for mHAgs to induce mortality by GVHD upon in vivo injection to irradiated recipients. 16 Here, the absence of overexpression of CD4V␤4 + and CD4V␤10 + subpopulations in the liver of LS mice, which were however detected in the liver of GVHD mice, may indicate that these cells recognize GVHD target antigens on host liver and thus are implicated in the pathological process. Altogether, these results reveal a clear difference in CD4 + T cell repertoire between recipients which do or do not develop an acute GVHD: V␤ subpopulations (V␤3, V␤6 as well as other V␤ families) are more frequently overexpressed in GVHD mice than in LS mice.
Contrary to CD4 + T cells, late infiltration of CD8 + T cells and overexpression of V␤ subpopulations occur in the lymph nodes and liver of both experimental groups whether or not the disease had developed. The pattern of predominant V␤ subpopulations is unique to each mouse however, as in the CD4 + compartment, V␤4 + subpopulations are frequently overexpressed in the CD8 + compartment of the liver of GVHD (40%) as well as in those of LS (60%) mice. In addition, the significant amplification of a given V␤ subpopulation correlates with the possible assignment of J␤ segment and/or junctional region, suggesting the expansion of one or a very limited number of clones. One obvious exception is the quasi-absence of amplification detected by cytofluorometry of the V␤2 family within the CD8 + compartment while it was found to be clonal or oligoclonal in five out of eight mice tested. This was later explained by the loss of the biotin-conjugated anti-V␤2 mAb activity. Such amplifications have been reported by Howell et al 7 in the CD4 + and CD8 + T cell repertoire of mice undergoing GVHD across mHAgs and Mtv-6 incompatibilities showing expansion of several V␤ T cell families in the liver and spleen. In addition, they described the repetitive and selective increase of CD4V␤3 + cells in response to Mls-2 a and of CD4V␤2 + cells in the liver which was likely to reflect a response to tissue Ag. Accordingly, in humans, amplification of V␣ and/or V␤ families was also described after autologous BMT and allogeneic BMT both in the presence or absence of GVHD suggesting no relationship to this pathological process. 9, 11, 13 Normal regulation of the T cell compartment following BMT, proposed by some authors 7,10,12 as a possible mechanism for overexpression, contributes marginally in our model because overexpression was only occasionally found in syngeneically reconstituted mice. The evidence of clonal or oligoclonal expansion of V␤ overexpressed subpopulations favors the hypothesis that amplification is not random but reflects an active antigen-driven immune response. Incompatible class I-and class II-associated mHAgs expressed on host GVHD target tissues are the best candidates involved in such V␤ amplifications although we cannot completely exclude peptides derived from exogenous pathogens. However, despite identical mHAg incompatibilities between recipients, the pattern of predominant V␤ subpopulations is individual and the identity of J␤ segment associated with a given V␤ segment differs between mice suggesting either the recognition of several mHAg epitopes which can each recruit T cells using different TCR or the activation by the same mHAg epitope of T cells expressing various TCR. In both cases, individual variability may be due to individual kinetics of disease development. Additionally, the higher frequency of T cell overexpression in the liver compared to the lymph nodes can reflect the preferential tissue distribution of specific GVHD target mHAgs in the liver.
The observation that the frequency of overexpressed V␤ subpopulations in LS mice is low within the CD4 + cell compartment and much higher in the CD8 + cell compartment must be related to the inability of CD4 + cells to proliferate and conversely to the capacity of CD8 + cells to be cytotoxic in response to host mHAgs in LS mice 2-3 months after the graft. 20, 21 The absence of lethal GVHD in LS mice despite the activation of CD8 + T lymphocytes, antigenic specificity of which had not been defined, had also been reported by Fontaine et al 31 in other donor-recipient combinations. We proposed two hypotheses to explain these observations: firstly, CD8
+ T cells expanding in LS protected mice only recognize non-GVHD target mHAgs and, secondly, these expanding CD8 + T cells could participate in lethal GVHD as effectors of the disease but an insufficient amount of Mtv-SAgs-specific CD4 + helper activity prevents them being fully efficient. The subclinical GVHD that appears in LS mice between 3 and 6 months after the graft 21 and which is characterized by the progressive development of thymic atrophy and splenic T cell depletion, accounts for the latter hypothesis. However, despite the lack of mHAg-specific CD4 + T cell reactivity in LS mice, CD8
+ T cells are able to mediate a GVL against P815 tumor cells. 21 This observation together with other reports is in favor of a possible separation of GHVD and GVL 32 but investigations are required to identify effector T cells and antigens implicated in these two reactions. Altogether, the data presented in this study indicate that the absence of acute GVHD is associated with inhibition of the CD4 + T cell repertoire specific for Mtv-SAgs and mHAgs. Moreover, amplification of V␤ subpopulations within the CD8 + compartment is not predictive of an acute GVHD but may reflect the presence of a subclinical disease.
